Published in TB and Outbreaks Week, July 25th, 2000
Researchers in Mexico say malaria could be stopped in its tracks by genetically engineered mosquitoes that produce a scorpion toxin in their gut, according to an article in the July 8 issue of New Scientist.
Meanwhile, researchers in California are synthesizing similar compounds as immunosuppressants for treating transplant recipients and patients with autoimmune disorders (H. Wulff et al., Proceedings of the National Academy of Sciences, July 3, 2000; and see the July 26 issue of NewsRx.com's Immunotherapy Weekly).
For years, scientists have dreamed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week